| Medicare CGS | Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (57870) | 2026-09-15 |
| Medicare CGS | Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (57873) | 2026-09-15 |
| Medicare CGS | Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (60215) | 2026-09-15 |
| Medicare Noridian | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (57037) | 2026-09-15 |
| Medicare Noridian | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (59868) | 2026-09-15 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (59872) | 2026-09-15 |
| Medicare Noridian | Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (60217) | 2026-09-15 |
| Medicare Palmetto | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (56943) | 2026-09-15 |
| Medicare Palmetto | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (59847) | 2026-09-15 |
| Medicare Palmetto | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (59849) | 2026-09-15 |